Ankara City Hospital
Ankara, Çankaya, 06660, Turkey (Türkiye)
Location contact
Ceyhun Çağlar, MD, Assoc. Prof.
PRINCIPAL_INVESTIGATOR
Serhat Akçaalan, MD, Assoc. Prof.
CONTACT
Yavuz Şahbat, MD
CONTACT
NCT Number: NCT07582081
This prospective blinded study aims to investigate the relationship between objectively measured sleep parameters and patient-reported sleep and functional outcomes in patients undergoing reverse shoulder arthroplasty. Sleep will be assessed using MotionWatch 8, and outcomes will be correlated with validated clinical scores. This study is designed as a prospective, blinded clinical investigation conducted at a single tertiary referral center. Patients undergoing reverse shoulder arthroplasty for cuff arthropathy or glenohumeral osteoarthritis will be consecutively enrolled.
Objective sleep parameters will be collected using MotionWatch 8 one week prior to surgery in the patients' home environment. Functional and subjective sleep assessments will be performed preoperatively using validated scoring systems including ASES, Constant-Murley Score, VAS, SST, PSQI, and Jenkins Sleep Scale.
Postoperative follow-up will include reassessment of functional scores at 1, 3, and 6 months. At the 6-month follow-up, both subjective sleep assessments and objective sleep measurements will be repeated.
The primary objective is to evaluate the correlation between objective sleep parameters and ASES and PSQI scores.
Trial opening soon.
Get Notified18 year–90 year
All sexes
Observational
Ankara, Çankaya, 06660, Turkey (Türkiye)
Ceyhun Çağlar, MD, Assoc. Prof.
PRINCIPAL_INVESTIGATOR
Serhat Akçaalan, MD, Assoc. Prof.
CONTACT
Yavuz Şahbat, MD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients undergoing reverse shoulder arthroplasty Diagnosis of cuff arthropathy or glenohumeral osteoarthritis Age ≥18 years Ability to provide informed consent
Exclusion criteria
Refusal to participate Known psychiatric disorders Pre-existing diagnosed sleep disorders or ongoing treatment for sleep disturbances Pathology affecting the contralateral shoulder Inability to comply with study protocol
Time frame: 6 months postoperatively
The primary outcome is the strength of association between objective sleep parameters measured by actigraphy (MotionWatch 8), including total sleep time, sleep efficiency, sleep latency, and nocturnal activity, and patient-reported outcome measures, specifically the American Shoulder and Elbow Surgeons (ASES) score and Pittsburgh Sleep Quality Index (PSQI).
Ankara City Hospital Bilkent
Other
Correlation Between Objective Sleep Parameters Measured by MotionWatch 8 and Functional Outcomes in Patients Undergoing Reverse Shoulder Arthroplasty: A Prospective Blinded Study
Acronym: Sleep and RSA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07023913
Dysfunction, Kinetic Control
Cairo, Egypt
View Trial DetailsNCT06323980
Arthroplasty, Replacement
Irvine, California, United States
View Trial DetailsNCT06447493
Neurologic Manifestations, Pain
Auburn, Alabama, United States
View Trial DetailsNCT07510893
Athlete, Performance Enhancement
Ankara, Sıhhıye, Turkey (Türkiye)
View Trial Details